Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Tuesday, November 10, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 31
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
EMA Adopts a New Pharmaceutical Form of Selumetinib
Ogkologos
-
December 16, 2025
0
FDA Approves Pembrolizumab with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer
Ogkologos
-
December 15, 2025
0
Postneoadjuvant Trastuzumab Deruxtecan Results in Higher Likelihood of iDFS Among Patients...
Ogkologos
-
December 12, 2025
0
Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate...
Ogkologos
-
December 11, 2025
0
Patient Guide in Prostate Cancer Now Available in Vietnamese
Ogkologos
-
December 10, 2025
0
Efficacy of Talquetamab Plus Teclistamab in Patients with Extramedullary Myeloma
Ogkologos
-
December 10, 2025
0
One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides...
Ogkologos
-
December 9, 2025
0
EMA Recommends Granting a Marketing Authorisation for Accordpharma Enzalutamide
Ogkologos
-
December 5, 2025
0
FDA Approves Durvalumab for Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma
Ogkologos
-
December 5, 2025
0
Ahead of ESMO Immuno-Oncology Congress 2025: topics at a glance
Ogkologos
-
December 4, 2025
0
1
...
30
31
32
...
432
Page 31 of 432
MOST POPULAR
Adding Relacorilant to Nab-paclitaxel Prolongs OS in Patients with Platinum-Resistant Ovarian...
April 21, 2026
Is AI Ready to Play a Leading Role in Colorectal Cancer...
October 10, 2023
A celebration of peer review
September 21, 2021
Final Results of the Collaborative EORTC/Intergroup Randomised Phase III Study of...
February 24, 2021
Load more
HOT NEWS
Distinct Patient, Tumour, Treatment Characteristics and a Different Pattern and Risk...
First-Line Triplet Combination of Zolbetuximab, mFOLFOX6 and Nivolumab Supports Targeting CLDN18.2...
EMA Recommends Extending Indications for Pembrolizumab to Include Adjuvant Treatment in...
ΗΛΕΚΤΡΟΧΗΜΕΙΟΘΕΡΑΠΕΙΑ: Η ΝΕΑ ΠΡΩΤΟΠΟΡΙΑΚΗ ΠΡΟΣΕΓΓΙΣΗ ΓΙΑ ΘΕΡΑΠΕΙΑ ΟΓΚΩΝ
Ελληνικά
English (UK)